Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06289569 · ClinicalTrials.gov registry record · NA
Home Tele Rehabilitation Therapy for Vascular Dementia
A NA study of Dementia, Vascular and Stroke Sequelae, sponsored by The Methodist Hospital Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06289569: Recruiting NA study of Dementia, Vascular and Stroke Sequelae, sponsored by The Methodist Hospital Research Institute.
NCT06289569 is a NA study of Dementia, Vascular and Stroke Sequelae that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 120 participants, below the 1,213-participant average among 10 other Dementia, Vascular trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06289569, a NA study of Dementia, Vascular and Stroke Sequelae, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine whether the home telerehabilitation therapy is feasible and lessens caregiver burden in chronic stroke patients with and without vascular dementia (VaD)
Primary Outcome
Burden Scale for Family Caregivers BSFC-s\[8\] Subjective caregiver burden 10-item short version of the questionnaire.
Conditions Studied
Interventions
- OTHER Home telerehabilitation therapy
Study Locations (1)
Texas
- Houston Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-12-14 |
| Est. Completion | 2028-04-01 |
| Phase | NA |
What NCT06289569 shows while recruiting
NCT06289569 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,213-participant average among 10 other Dementia, Vascular trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Dementia, Vascular appearing as the primary indexed condition, and to 1 intervention - of which Home telerehabilitation therapy is the first listed.
NCT06289569 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06289569 about?
NCT06289569 is a clinical study titled "Home Tele Rehabilitation Therapy for Vascular Dementia". To determine whether the home telerehabilitation therapy is feasible and lessens caregiver burden in chronic stroke patients with and without vascular dementia (VaD)
What is the current status of trial NCT06289569?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-12-14. Estimated completion is 2028-04-01.
What conditions does trial NCT06289569 study?
This clinical trial studies the following conditions: Dementia, Vascular, Stroke Sequelae.
What interventions are being tested in trial NCT06289569?
The interventions under investigation include: Home telerehabilitation therapy (OTHER).
Who is sponsoring clinical trial NCT06289569?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06289569 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia, Vascular
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06289569's enrollment target sits among peer trials
120 9th of 10 higher than 2 of 10 other Dementia, Vascular trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia, Vascular trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
RECRUITING · NA
-
Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients
ACTIVE NOT RECRUITING · NA
-
LEAD IT! An App to Enable Persons With Early Stage Dementia to Lead Group Activities for Their Peers
COMPLETED · NA
-
Zolpidem CR and Hospitalized Patients With Dementia
COMPLETED · NA
-
Rural Dementia Caregiver Project
COMPLETED · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI